companiesSEC EDGAR
Theravance Biopharma, Inc.
SEC EDGAR published this disclosure on 2026-08-11. Read the original document for its full text and supporting detail.
Open the original document at SEC EDGAR ↗accession0001104659-26-093773
cik1583107
company nameTheravance Biopharma, Inc.
form10-Q